Loading clinical trials...

COMPLETEDPHASE1

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction

NCT06060691•Deraya University

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API

Eligibility

Age

28 - 45 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Women between the ages of 28 and 45
•had regular periods and previous menstrual bleeding lasted between three and seven days

Exclusion Criteria

•sensitivity to drug of therapy,
•cancer,
•autoimmune illness,
•smoking or drinking,
•liver disease,
•irregular menstruation

Locations (1)

Soad A. Mohamad

Minya, Egypt

Key Dates

Start Date

September 20, 2023

Primary Completion Date

December 30, 2023

Completion Date

February 1, 2024

Last Updated

May 16, 2024

Enrollment

ACTUAL participants

Conditions

Female Sexual Dysfunction

Interventions

Kaempferol

DRUG

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

NCT06116045

Female Sexual Arousal DisorderFemale Sexual Dysfunction

View study

ACTIVE_NOT_RECRUITINGPHASE2

Sexual Effects of Transdermal or Vaginal Testosterone

NCT06794346

Female Sexual DysfunctionPostmenopausal Symptoms+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 16, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Inclusion Criteria

Exclusion Criteria

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

Sexual Effects of Transdermal or Vaginal Testosterone

Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction

Validation of iPelvis App for Female Pelvic Floor Dysfunction

Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function